INTRODUCTION {#sec1}
============

*Yarrowia lipolytica* is an attractive host organism for industrial production of biofuels and chemicals (Nicaud [@bib27]; Ganesan *et al*. [@bib14]; Miller and Alper [@bib24]). It is a non-conventional oleaginous yeast that is Generally Regarded as Safe (GRAS) and is amenable to metabolic engineering thanks to the availability of its genome sequence and wide array of genetic tools.

Numerous promoters have been identified and developed for metabolic pathway engineering efforts in *Y. lipolytica* (reviewed in (Madzak [@bib22]; Larroude *et al*. [@bib20]; Ganesan *et al*. [@bib14])). The promoter from the *Y. lipolytica* alkaline extracellular protease *XPR2* gene, was one of the first promoters identified and is still widely used (Blanchin-Roland, Cordero Otero and Gaillardin [@bib4]). While p*XPR2* is capable of strong expression of heterologous proteins, it is repressed at pH \< 5.5 and requires rich media for full induction (Ogrydziak, Demain and Tannenbaum [@bib29]). This type of complex regulation system is not compatible with many industrial processes. Strong promoters were also identified from translation elongation factor-1α (*TEF1*), ribosomal protein S7 (*RPS7*) (Müller *et al*. [@bib26]), isocitrate lyase (*ICL1)*, 3-oxo-acyl-CoA thiolase (*POT1)* and acyl-CoA oxidases (*POX2*) (Juretzek *et al*. [@bib19]). While p*TEF1*, p*RPS7* and p*ICL1* are used as constitutive promoters, p*POT1* and p*POX2* are repressed by glucose and active only in the presence of fatty acids, their derivatives, or alkanes (Müller *et al*. [@bib26]; Juretzek *et al*. [@bib19]). These types of preferences limit their usage in bioprocess applications. The *EYK1* promoter is induced using erythrose and erythrulose (Trassaert *et al*. [@bib33]). This promoter can enable tight modulation of protein levels but requires a process change (addition of an inducer), limiting the culture media that can be used and adding to fermentation cost. The *YAT1* promoter is induced during lipid accumulation and can be used to specifically turn on an activity during this phase of *Y. lipolytica* fermentation (Xue and Zhu [@bib36]). Hybrid promoters fusing multiple copies of upstream activating sequences (UAS) to a core promoter region have also been developed resulting in improved promoter performance (Madzak, Tréton and Blanchin-Roland [@bib23]; Blazeck *et al*. [@bib6], [@bib7]; Shabbir Hussain *et al*. [@bib31]; Trassaert *et al*. [@bib33]). Lacking from this toolbox are promoters that are naturally downregulated during lipid accumulation in order to specifically affect this phase during an industrial lipid production process.

Accumulation of lipid in *Y. lipolytica* is triggered by nutrient limitation in the presence of excess carbon. Nitrogen limitation is commonly used for lipid accumulation studies because it is an easily controlled parameter (Beopoulos *et al*. [@bib3]; Ochoa-Estopier and Guillouet [@bib28]; Friedlander *et al*. [@bib13]). A typical fermentation for the production of lipids has two phases: a growth phase in which there is enough nitrogen present for the cells to divide and produce catalytic biomass, and a lipid production phase in which nitrogen depletion causes a decrease in growth rate and activation of lipid synthesis and storage. The process involves a high carbon to nitrogen ratio (C:N) such as 50:1 ([@bib1]) or 100:1 (Qiao *et al*. [@bib30]) and the initial nitrogen concentration dictates the amount of lipid-free biomass. At the transition from growth phase to lipid accumulation, some pathways are repressed (nucleic acid and protein synthesis) and others are activated (fatty acid and triacylglycerol (TAG) synthesis) (Beopoulos *et al*. [@bib3]; Morin *et al*. [@bib25]; Ochoa-Estopier and Guillouet [@bib28]).

In this study, we describe promoters which reduce gene expression at the natural transition of *Y. lipolytica* from biomass production to lipid accumulation. Use of these promoters ties regulation of gene expression into established methods of lipid production without changing the fermentation process. By linking the expression of two desaturase genes to these promoters, we show that we can change the cellular lipid profile in the lipid accumulation phase without the need for culture additives.

MATERIALS AND METHODS {#sec2}
=====================

Strains and media {#sec2-1}
-----------------

Wild-type *Y. lipolytica* strain YB-392 was obtained from the ARS Culture Collection (NRRL). *Y. lipolytica* fatty acid desaturase deletion strains *Δole1* and *Δfad2* were previously described and each contains a single gene replacement with the hygromycin-resistance gene in the YB-392 background (Tsakraklides *et al*. [@bib35]) (Table [1](#tbl1){ref-type="table"}). Strains were cultured in YPD (10 g/L yeast extract, 20 g/L bacto peptone and 20 g/L glucose) at 30°C. 20 g/L agar was added to prepare solid media. *Δole1* strains were grown in YPD supplemented with 1% Tween 80 and 0.01% oleic acid. Antibiotic selection was achieved with the addition of hygromycin B (300 μg/mL) or nourseothricin (500 μg/mL) as appropriate (Tsakraklides *et al*. [@bib35]). Strains were characterized in sterilized lipid production media (0.5 g/L urea, 1.5 g/L yeast extract, 0.85 g/L casamino acids, 1.7 g/L Yeast Nitrogen Base without amino acids and ammonium sulfate, 100 g/L glucose and 5.11 g/L potassium hydrogen phthalate) in 96-well (300 μL per well) or 24-well (1.5 mL per well) deep-well plates, or in 250 mL flasks (25 mL per culture) (Friedlander *et al*. [@bib13]).

###### 

Strains used in this study.

  Strain      Genotype                           Reference
  ----------- ---------------------------------- ----------------------------------
  YB-392      *Y. lipolytica* wild-type strain   ARS Culture Collection (NRRL)
  *Δfad2*     *FAD2::hyg* in YB-392              (Tsakraklides *et al*. [@bib35])
  p1-*FAD2*   p1-FAD2 in *Δfad2*                 This work
  p2-*FAD2*   p2-FAD2 in *Δfad2*                 This work
  p3-*FAD2*   p3-FAD2 in *Δfad2*                 This work
  p4-*FAD2*   p4-FAD2 in *Δfad2*                 This work
  p5-*FAD2*   p5-FAD2 in *Δfad2*                 This work
  *Δole1*     *OLE1::hyg* in YB-392              (Tsakraklides *et al*. [@bib35])
  p1-*OLE1*   p1-*OLE1* in *Δole1*               This work
  p4-*OLE1*   p4-*OLE1* in *Δole1*               This work
  p5-*OLE1*   p5-*OLE1* in *Δole1*               This work

Gene overexpression cassettes {#sec2-2}
-----------------------------

Linear expression constructs were prepared using standard molecular biology techniques (all sequences in Additional File 1). Each expression construct contained an expression cassette for the desaturase gene of interest (*OLE1* or *FAD2*) driven by the promoters described in this study, in tandem with an expression cassette for the nourseothricin selectable marker. Promoters and desaturase gene sequences were amplified from YB-392 genomic DNA and all constructs were confirmed by sequencing of the expression cassettes.

Transformation {#sec2-3}
--------------

Log-phase *Y. lipolytica* cells were washed with water and resuspended in a volume of water equal to the wet cell pellet. 50 μL was aliquoted per transformation reaction. 18 μL of desired DNA and 92 μL of transformation mix (80 μL 60% PEG4000, 5 μL 2 M DTT, 5 μL 2 M lithium acetate pH 6 and 2 μL 10 mg/mL single stranded salmon sperm DNA) were added to the cell pellet. The transformation reaction was mixed by vortexing and heat shocked at 39°C for 1 h (Chen, Beckerich and Gaillardin [@bib8]; Friedlander *et al*. [@bib13]). Cells were centrifuged, the supernatant was discarded, cells were resuspended in 1 mL of non-selective medium (YPD for *Δfad2* or supplemented YPD as described above for *Δole1*), transferred to culture tubes and cultured overnight at 30°C before plating 100 μL on selective media.

Relative fatty acid composition measurement {#sec2-4}
-------------------------------------------

To obtain a relative fatty acid composition profile, a plate transesterification procedure was used to extract and convert lipids to fatty acid methyl esters (FAMEs). 1-mL samples from shake flasks were washed with water and transferred to a 96-well deep-well plate. Cells were resuspended in a small amount of water (∼50 μL) and frozen at −80°C for 30 min before placing the entire plate in a lyophilizer overnight. To each well 0.25 mL 0.5 M sodium methoxide in methanol (Acros Organics) was added and the plate was sealed closed and incubated at 50°C for 30 min with mixing by vortexing at 15 min. 0.25 mL of 0.6 N hydrochloric acid in water and 1 mL isooctane were then added to each well and mixed by pipetting. The plate was centrifuged at 3500 rpm at 22°C to separate the organic and aqueous layers. A sample of the FAME-containing isooctane layer (top layer) was analyzed by gas chromatography (GC) equipped with a flame ionization detector (Agilent Technologies 7890B GC) and VF-23 ms capillary column (20 m × 0.15 mm × 0.15 µm, Agilent Technologies). The fatty acid composition was determined as % of total peak area (sum of C16:0, C16:1, C18:0, C18:1 and C18:2) for each FAME species (Christie and Esterification [@bib9]). Because the dry cell weight in each of the 96 wells is not measured, this method yields relative compositional analysis by comparing peak areas within each sample, but not absolute fatty acid levels (Tsakraklides *et al*. [@bib35]).

Total lipid quantitation {#sec2-5}
------------------------

To obtain the total lipid content and lipid composition from a sample, a quantitative GC procedure was used. The samples were processed and lyophilized as above in the fatty acid composition measurement except that each sample was lyophilized in separate vials. The dried biomass was weighed and subjected to acid-catalyzed transesterification along with an internal standard (C13:0) using 1.25 M hydrochloric acid in methanol (Sigma) at 85°C for 90 min. After the transesterification, the lipid-soluble components of the reaction mixture were separated from the water-soluble components using a two-phase liquid extraction by adding water and isooctane, and subsequently analyzed by GC. The internal standard was used to correct for transesterification reaction efficiency. An external standard mix of FAMEs (NHI-D, Supelco Analytical, Bellefonte, PA) at various concentrations was used to quantify the methyl-ester products. The % lipid content is calculated as the sum of FAMEs divided by the weight of the dried biomass.

RNA extraction and transcript quantification {#sec2-6}
--------------------------------------------

A total of 20 OD~600~ units of culture was removed from shake flask fermentations at 16 h and 96 h, washed with water and stored at −80°C. Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad CA). Genomic DNA was removed using DNase (Qiagen, Germantown MD) followed by RNA cleanup using the RNeasy Mini Kit (Qiagen). A total of 500 ng of clean RNA was used for cDNA synthesis using M-MuLV Reverse Transcriptase enzyme (NEB). PCR quantification was performed by Wyzer Biosciences (Cambridge, MA) using PerfeCTa SYBR qPCR mix with High ROX (QuantaBio, Beverly MA) as a reference dye. The reactions were run in triplicate in PCR-96-LP-AB-C plates (Corning) on a StepOnePlus real-time PCR system (Applied Biosystems, Foster City CA). Software analysis was performed with StepOne v.2.3 software (Applied Biosystems). Gene expression levels were standardized using the *Y. lipolytica* actin gene *ACT1* as a reference (ΔCT method). For comparisons to YB-392 at 16 h, the 2^−ΔΔCT^ method was used to calculate fold change. The 2^−ΔΔCT^ method was also used for measuring fold repression for each strain, between the 16 h timepoint and 96 h timepoint (Livak and Schmittgen [@bib21]). The qPCR primers used were *OLE1* F: 5′-CACAACCTGCTTGCCACCATG-3′, *OLE1* R: 5′-CAGCTCGGTGGATTCGGTTTC-3′, *FAD2* F: 5′-CCATGACATCATCGAGACCCACG-3′, *FAD2* R: 5′-GTTGGTGTCGTCGTGTCGGTAG-3′, *ACT1* F: 5′-GCTGCTGGTATCCACGAGACTAC-3′, *ACT1* R: 5′-GCGGAGATCTCCTTGTGCATTCG-3′.

RESULTS {#sec3}
=======

Identification of candidate promoters for reduced expression during lipid accumulation {#sec3-1}
--------------------------------------------------------------------------------------

To identify promoters that could be used to mediate distinct lipid phenotypes in the growth and lipogenesis phases through reduced gene expression during lipid accumulation, we analyzed a published *Y. lipolytica* transcriptomic dataset (GEO [@bib16],[@bib17],[@bib18]) acquired in Ochoa-Estopier and Guillouet ([@bib28]) and analyzed in Trébulle *et al*. ([@bib34]). In that experiment, *Y. lipolytica* W29 was cultivated under chemostat and decelerostat (D-stat) conditions. During chemostat growth, cells were supplied with enough nutrients to maintain continuous growth. During D-stat cultivation, the C:N ratio was adjusted by a linear decrease of the nitrogen feed. We compared transcript levels between chemostat growth (reference sample in GEO [@bib16],[@bib17],[@bib18])) and D-stat cultivation at a C:N molar ratio of 31 (sample 47, 0.0323 N:C molar ratio at 166 h in GEO ([@bib16],[@bib17],[@bib18])). This timepoint was selected because the culture reached a maximal respiratory quotient (RQ) value at this time, indicating potentially high lipid production (Ochoa-Estopier and Guillouet [@bib28]). We identified transcripts with more than 95% reduction between the two conditions and selected the promoters from five of these transcripts with a range of reduction of 20- to 51-fold for further study (p1--p5, Table [2](#tbl2){ref-type="table"}). The *Y. lipolytica* genes transcribed by these promoters have similarity to amino acid permeases (p1, p5), a gene involved in cell wall synthesis and maintenance (p2), or proteins of unknown function (p3, p4).

###### 

Promoters used in this study.

  Promoter   Gene           Location relative to ATG   Gene annotation (NCBI Gene Database (Gene [@bib15]))                                             Transcript reduction at high C:N (GEO [@bib16],[@bib17],[@bib18])
  ---------- -------------- -------------------------- ------------------------------------------------------------------------------------------------ -------------------------------------------------------------------
  p1         YALI0B16522g   −1000 to −1                Similar to uniprot\|P19145 *Saccharomyces cerevisiae* YKR039w GAP1 general amino acid permease   51
  p2         YALI0C01411g   −1000 to −1                Similar to uniprot\|Q9UVK9 *Yarrowia lipolytica* Fks1p                                           34
  p3         YALI0A04631g   −370 to −1                 Weakly similar to uniprot\|Q6C9E1 *Yarrowia lipolytica* YALI0D11924g                             32
  p4         YALI0A12815g   −1000 to −1                No similarity                                                                                    28
  p5         YALI0B19800g   −1000 to −1                Similar to uniprot\|P19145 *Saccharomyces cerevisiae* YKR039W GAP1 General amino acid permease   20

To assay the activity of these promoters, we used the 1000 bp (or 370 bp for p3 where the intergenic region is shorter) upstream of each transcription start site to drive transcription of two lipid-related reporter genes: Δ12 fatty acid desaturase (*FAD2*) and Δ9 fatty acid desaturase (*OLE1*). The promoter sequence length chosen was based on the observation that most promoters used in *Y. lipolytica* strain engineering extend 300--1000 bp upstream from the transcription start site (Blazeck *et al*. [@bib5]). The desaturase genes were chosen as reporter genes because we could track desaturase activity through changes in fatty acid composition (Tsakraklides *et al*. [@bib35]). As opposed to the D-stat experiment in Ochoa-Estopier and Guillouet ([@bib28]), all characterizations in the present study were performed in batch fermentation in lipid production media for up to 6 days (starting C:N molar ratio of 100). These conditions allow for growth during the first day while nitrogen is available to produce biomass, and subsequent lipid accumulation through the following days when nitrogen is depleted (Friedlander *et al*. [@bib13]). Our goal was to identify promoters that result in changes in fatty acid composition specific to the lipid accumulation phase.

Control of Δ12 fatty acid desaturase expression {#sec3-2}
-----------------------------------------------

*Yarrowia lipolytica* Δ12 fatty acid desaturase (*FAD2, YALI0B10153)* adds a double bond in the Δ12 position of oleyl phospholipid (C18:1) to produce linoleyl phospholipid (C18:2). Linoleate can subsequently be incorporated into storage lipids through fatty acid exchange between phospholipid and TAG synthesis pathways (Yuan and Bloch [@bib37]; Ferrante and Kates [@bib12]; Dahlqvist *et al*. [@bib10]). It was previously demonstrated that deleting the *FAD2* gene leads to elimination of all detectable linoleate (Tezaki *et al*. [@bib32]; Tsakraklides *et al*. [@bib35]). Therefore, the *Δfad2* background was chosen to characterize linoleate composition in strains expressing *FAD2* under the control of p1-p5 without interference from the endogenous locus.

We examined linoleate content in strains carrying p1--p5 constructs. Linear cassettes driving *FAD2* expression from each of the promoters under study, paired with an antibiotic resistance constitutive expression cassette (Additional file 1) were transformed into a *Δfad2* strain. This *Δfad2* strain was previously created by deletion of the endogenous *FAD2* gene in the wild-type haploid strain YB-392 (Tsakraklides *et al*. [@bib35]). Random integration of linear constructs into the genome leads to a range of phenotype expressivity. To select representative strains rather than outliers, we compared linoleate levels at the end of the lipid accumulation phase between the native *FAD2*-expressing wild-type strain YB-392 and 12 transformants from each construct (Fig. [1a](#fig1){ref-type="fig"}; complete lipid profiles can be found in Additional File 2). We observed the expected heterogeneity within each set of twelve transformants due to integration site variation but saw clear differences in the level of linoleate present in each group. Linoleate levels were lower than YB-392 in all cases. p5-*FAD2*, closely followed by p1-*FAD2* gave the highest linoleate levels among the engineered strains. p3- and p4-*FAD2* strains had very low levels of the Δ12-desaturated fatty acid. In p2-*FAD2* strains, linoleate was undetectable, similar to the *Δfad2* strain. To verify that linoleate absence was not due to failure to introduce the expression cassette, colony PCR was used to confirm the presence of the *FAD2* construct in all transformants (data not shown). These results indicate that p1-p5 all lead to lower-than-wild-type Δ12 fatty acid desaturase activity during lipid accumulation.

![Linoleate content of *FAD2* strains. **(A)** Wild-type strain YB-392, desaturase deletion strain *Δfad2* and 12 transformants of *Δfad2* with each of the *FAD2* constructs were grown in 96-well plates for 6 days. Relative fatty acid composition was determined by GC. The fraction of linoleate is shown as percentage of total fatty acids by GC peak area. **(B)** Two isolates from each of the transformant sets analyzed in (A) were grown in duplicate in 96-well plates and analyzed after 24 h (solid bars) and 96 h (hatched bars). Linoleate content was determined as in (A) and the average and standard deviation of duplicate cultures is shown.](foaa035fig1){#fig1}

To determine whether Δ12 fatty acid desaturase is downregulated under our fermentation conditions, we compared linoleate composition between growth and lipid accumulation phases in two isolates of average performance from each promoter set (Fig. [1b](#fig1){ref-type="fig"}; complete lipid profiles can be found in Additional File 2). Average performers represent promoter strength more accurately than outliers that likely reflect a particularly favorable or unfavorable integration event. YB-392 exhibited a reduction of linoleate from 24 to 96 h. Lipid accumulation involves increased fatty acyl-CoA storage into TAG leading to a final lipid content that is predominantly composed of storage lipids and a small fraction of phospholipids (Athenstaedt *et al*. [@bib2]). As the substrate and product of Δ12 desaturase are phospholipids (Ferrante and Kates [@bib12]), we hypothesize that the linoleate reduction in YB-392 is a result of the natural dilution of linoleate in storage TAG during lipid accumulation and will return to this question in a subsequent experiment (Fig. [3b](#fig3){ref-type="fig"}). By comparison, p2-*FAD2* strains failed to produce linoleate at 24 h as well as 96 h, suggesting very low activity. p1 and p3--p5 strains maintained the relative levels of linoleate seen in Fig. [1a](#fig1){ref-type="fig"} and showed a decrease in linoleate levels at 96 h compared to 24 h. This decrease was generally greater than that seen with YB-392, suggesting downregulation of *FAD2* in addition to dilution due to lipid accumulation.

Given the consistent results between the chosen average performers, the first of these two isolates for each promoter (from Fig. [1b](#fig1){ref-type="fig"}) was used as a representative strain for further characterization. Total lipid content at the end of lipid accumulation was similar in YB-392, *Δfad2* and the p1--p5 strains (Fig. [2](#fig2){ref-type="fig"}), indicating that changes in lipid accumulation do not account for the decreased linoleate levels observed. *FAD2* gene copy number was determined by qPCR and it was found that all strains contained 1 (YB-392 and p1, p2 and p3 strains) or 2 (p4 and p5 strains) copies of the *FAD2* gene (data not shown). Copy number would affect the absolute level of expression but should not affect the evaluation of phase-specific relative changes in fatty acid composition and transcription.

![Lipid content of *FAD2* strains. An isolate from each of the *FAD2* strains tested in Fig. [1](#fig1){ref-type="fig"}, desaturase deletion strain *Δfad2* and wild-type strain YB-392 were grown in duplicate in 24-well plates for 4 days. Lipid content was determined by quantitative GC as percentage of total dry cell weight (DCW). The average and standard deviation of duplicate cultures is shown.](foaa035fig2){#fig2}

Growth samples collected at 24 h contained lower than wild-type levels of linoleate (Fig. [1b](#fig1){ref-type="fig"}). Although this could be due to lower starting activity of p1--p5 compared to the native *FAD2* promoter, we speculated that p1--p5-mediated desaturase repression may occur earlier in the fermentation. To evaluate linoleate composition at an earlier timepoint, we collected growth samples from the selected isolates at 16 h and 96 h (Fig. [3a](#fig3){ref-type="fig"}). Relative fatty acid composition of p1 and p3--p5 strains showed higher linoleate values at 16 h than previously seen at 24 h and relative to YB-392 suggesting that desaturase activity under the control of these promoters may indeed already be diminished by 24 h. As previously seen, p5-*FAD2* and p1-*FAD2* strains exhibited the highest linoleate content during growth phase, followed by p3-*FAD2* and p4-*FAD2*. Observed linoleate levels for p4-*FAD2* and p5-*FAD2* strains are the result of Δ12 fatty acid desaturase expression from two copies of the expression cassette. It is expected that expression from a single copy would yield proportionately lower linoleate at both timepoints. Linoleate was again undetectable in the p2-*FAD2* strain even at 16 h.

![Fatty acid composition and *FAD2* transcript levels in *FAD2* strains. The selected strains were grown in 50-mL shake flasks and sampled at 16 h and 96 h. **(A)** Relative fatty acid composition was determined by GC. The fraction of each fatty acid is shown as percentage of total fatty acids by GC peak area. Data labels denote linoleate levels. **(B)** Linoleate composition (solid bars) and *FAD2* transcript levels (striped bars) normalized to the wild-type strain YB-392 at 16 h. **(C)** Microscope images of each strain at 96 h.](foaa035fig3){#fig3}

cDNA from the same samples was analyzed by qPCR to characterize promoter activity and relate transcription to lipid composition. For ease of comparison, the fraction of linoleate and the *FAD2* transcript levels of each sample were normalized to wild-type levels during growth (Fig. [3b](#fig3){ref-type="fig"}). The ratio of transcript levels and the ratio of % linoleate composition at 16 h to those at 96 h were also calculated to quantify changes between growth and lipid accumulation phases (Table [3](#tbl3){ref-type="table"}). In YB-392, *FAD2* expression from the native promoter is relatively stable between 16 h and 96 h but % linoleate composition is reduced 4.5-fold. This supports the hypothesis that linoleate reduction in YB-392 is a result of the natural dilution of linoleate during lipid accumulation rather than transcriptional changes. Promoters p1, p3, p4 and p5 show transcript reduction ranging from 2.6- to \> 1800-fold between growth and lipid accumulation. This transcriptional repression correlates with the sharper decrease in linoleate composition for these four promoters between the two timepoints (ranging from 7- to 18-fold) when compared to YB-392 (4.5-fold). Despite altered fatty acid composition, microscopic observation of the transformants at 96 h revealed no discernible defects in growth or lipid production and all strains appeared similar to the control strains (Fig. [3c](#fig3){ref-type="fig"}).

###### 

Comparison of *FAD2* transcription and linoleate composition between growth and lipid accumulation phases. *FAD2* transcript levels were measured by qPCR and fold-change between timepoints was calculated using the 2^−ΔΔCt^ method (Livak and Schmittgen [@bib21]). Ratios of percent linoleate composition were calculated by dividing percent linoleate values at 16 h by those at 96 h using the data presented in Fig. [1a](#fig1){ref-type="fig"}. ND: not detected.

  Strain          Ratio of *FAD2* transcript at 16 h / 96 h   Ratio of linoleate composition at 16 h / 96 h
  --------------- ------------------------------------------- -----------------------------------------------
  p1-*FAD2*       178                                         15
  p2-*FAD2*       0.3                                         ND
  p3-*FAD2*       8.8                                         14
  p4-*FAD2*       2.6                                         7
  p5-*FAD2*       1855                                        18
  *Δfad2*         ND                                          ND
  YB-392 (*wt*)   1.1                                         4.5

Control of Δ9 fatty acid desaturase expression {#sec3-3}
----------------------------------------------

To investigate the potential of these promoters to control an essential gene, we extended our study to the expression of Δ9 fatty acid desaturase. *Y. lipolytica* Δ9 desaturase (*OLE1*, *YALI0C05951*) acts on saturated palmitic (C16:0) and stearic (C18:0) fatty acids to produce the corresponding unsaturated palmitoleic (C16:1) and oleic (C18:1) fatty acids. *OLE1* is an essential gene. Its deletion leads to auxotrophy for monounsaturated fatty acids; reintroduction of an active Δ9 desaturase rescues growth on unsupplemented media (Tsakraklides *et al*. [@bib35]).

The promoters under study were evaluated in a Δ9 desaturase null strain. *OLE1* was previously deleted by targeted integration in wild-type strain YB-392 (Tsakraklides *et al*. [@bib35]). *Δole1* was cultured in media supplemented with oleic acid to maintain viability and transformed with expression cassettes for *OLE1* driven by p1--p5. Transformants were selected through antibiotic resistance on supplemented plates and then tested for their ability to grow on unsupplemented media. Expression of *OLE1* from promoters p1, p4 and p5 enabled growth on media without supplementation, indicating that sufficient Δ9 desaturase activity was produced during growth to supply essential monounsaturated fatty acids. p2--p3 strains and the parental *Δole1* strain, could not grow without supplementation suggesting that *OLE1* expression was below levels necessary for growth. Therefore, these strains were excluded from subsequent analysis as they cannot grow in the lipid production media which does not contain monounsaturated fatty acids.

Transformants of p1-, p4- and p5-*OLE1* were grown, sampled and analyzed as for the *FAD2* experiment. To better visualize the effect of *OLE1* expression, Δ9 desaturase products (C16:1, C18:1 and C18:2, a Δ12 desaturation product of C18:1) were combined. In the 12-transformant screen, all transformants showed a similar reduction in Δ9-desaturated fatty acid content at the end of lipid accumulation compared to the wild-type strain (Fig. [4a](#fig4){ref-type="fig"}; complete lipid profiles can be found in Additional File 2). When 2 representative isolates were re-examined at 24 h and 96 h, the engineered strains each showed higher Δ9-desaturated fatty acid content during the growth phase than the lipid accumulation phase and all showed lower Δ9-desaturated fatty acid content than YB-392 at both timepoints (Fig. [4b](#fig4){ref-type="fig"}; complete lipid profiles can be found in Additional File 2). For each promoter, the first of these two isolates was used as a representative strain for further characterization. These three chosen strains each contained a single copy of the *OLE1* gene as determined by qPCR (data not shown). Total lipid content during lipid accumulation was significantly lower than YB-392 (Fig. [5](#fig5){ref-type="fig"}). *OLE1* is known to be an important gene in the lipid production pathway (Dobrzyn and Ntambi [@bib11]; Qiao *et al*. [@bib30]), and low Δ9 desaturase levels could explain this phenotype.

![Δ9-desaturated fatty-acid content of *OLE1* strains. **(A)** Wild-type strain YB-392 and 12 transformants from each of the *OLE1* constructs in *Δole1* were grown in 96-well plates for 4 days. Relative fatty acid composition was determined by GC. The fraction of Δ9-desaturated fatty acids is shown as the sum of palmitoleate (C16:1), oleate (C18:1) and linoleate (C18:2) as a percentage of total fatty acids. **(B)** Two isolates from each of the transformant sets analyzed in (A) were grown in duplicate in 96-well plates and analyzed after 24 h (solid bars) and 96 h (hatched bars). Δ9-desaturated fatty acid content was determined as in (A) and the average and standard deviation of duplicate cultures is shown.](foaa035fig4){#fig4}

![Lipid content of *OLE1* strains. An isolate from each of the *OLE1* strains tested in Fig. [4](#fig4){ref-type="fig"} and wild-type strain YB-392 were grown in duplicate in 24-well plates for 4 days. Lipid content was determined by quantitative GC as percentage of total dry cell weight (DCW). The average and standard deviation of duplicate cultures is shown.](foaa035fig5){#fig5}

We next evaluated fatty acid composition and *FAD2* transcription in the selected strains at 16 h and 96 h. Composition measurements revealed varying lipid profiles for p1, p4 and p5 transformants compared to each other and compared to the wild-type strain (Fig. [6a](#fig6){ref-type="fig"}). Δ9-desaturated fatty-acids and *OLE1* transcript levels were normalized to the 16 h timepoint for YB-392 (Fig. [6b](#fig6){ref-type="fig"}) and the ratios of Δ9-desaturated fatty-acids and *OLE1* transcript levels between growth and lipid accumulation were calculated (Table [4](#tbl4){ref-type="table"}). p1-, p4- and p5-*OLE1* strains all exhibited a reduction of Δ9 desaturated fatty acids by 96 h but this was more modest (1.8-fold) than the change in transcript levels (63- to 688-fold) between the two timepoints (Table [4](#tbl4){ref-type="table"}). Low lipid level (Fig. [5](#fig5){ref-type="fig"}) is likely responsible for the retention of a significant fraction of Δ9-desaturated fatty acids in the total lipid composition despite the loss of Δ9 desaturase transcript at 96 h. Microscopic examination revealed a reduction in the size of lipid bodies in all three strains when compared to wild-type YB-392, confirming a defect in lipid accumulation (Fig. [6c](#fig6){ref-type="fig"}). In the absence of new lipid production, the desaturated fatty acids produced during growth remain a significant portion of total lipid content. It is important to keep in mind that the wild-type strain accumulates approximately 3.7-fold more lipid (∼22% of its dry cell weigh as opposed to ∼6% in the engineered strains; Figs [5](#fig5){ref-type="fig"} and [6c](#fig6){ref-type="fig"}). Therefore, at the end of lipid accumulation, the higher Δ9-desaturated fatty acid composition of YB-392 compared to the lower-lipid engineered strains (Fig. [6b](#fig6){ref-type="fig"}) in fact translates to an even higher absolute quantity of accumulated Δ9-desaturated fatty acids in YB-392.

![Fatty acid composition and *OLE1* transcript levels in *OLE1* strains. **(A)** Relative fatty acid composition was determined by GC. The fraction of each fatty acid is shown as percentage of total fatty acids by GC peak area. **(B)** Δ9 fatty acid composition (solid bars) and *OLE1* transcript levels (striped bars) normalized to the wild-type strain YB-392 at 16 h. **(C)** Microscope images of each strain at 96 h.](foaa035fig6){#fig6}

###### 

Comparison of *OLE1* transcription and Δ9 desaturated fatty acid composition between growth and lipid accumulation phases. *OLE1* transcript levels were measured by qPCR and fold-change between timepoints was calculated using the 2^−ΔΔCt^ method (Livak and Schmittgen [@bib21]). Ratios of percent desaturated fatty acid composition were calculated by dividing percent fatty acid values at 16 h by those at 96 h using the data presented in Fig. [2a](#fig2){ref-type="fig"}.

  Strain        Ratio of *OLE1* transcript at 16 h / 96 h   Ratio of Δ9 product composition at 16 h / 96 h
  ------------- ------------------------------------------- ------------------------------------------------
  p1-*OLE1*     63                                          1.8
  p4-*OLE1*     63                                          1.8
  p5-*OLE1*     688                                         1.8
  YB-392 (wt)   1.2                                         1.1

DISCUSSION {#sec4}
==========

In this study, we set out to expand the *Y. lipolytica* metabolic engineering toolbox through the identification of promoters that are downregulated during the switch to lipogenesis. We identified four native promoters capable of mediating distinct phenotypes between the growth and lipid accumulation phases of a typical nitrogen-limited *Y. lipolytica* fermentation. The desaturase genes *FAD2* and *OLE1* were chosen to illustrate the ability to modify fatty acid profiles. These enzymes are directly involved in lipid synthesis and, therefore, could help translate transcriptional effects to lipid phenotypes. Lipid composition and transcript level data were collected to characterize the promoters and demonstrate the range of phenotypes attainable. Overall, we found agreement between reduced transcript levels and reduced product for the targeted activity during lipid accumulation in strains expressing desaturases driven by promoters p1, p3, p4 and p5.

p2 was included in our study because it was reported to be active (Ochoa-Estopier and Guillouet [@bib28]; Trébulle *et al*. [@bib34]). However, p2-driven *OLE1* failed to complement *Δole1* and led to very low or undetectable linoleate and *FAD2* transcript levels. We speculate that the differences between our results are related to the differences between the two experimental setups. We reasoned that the region 1000 bp upstream of the transcription start site may contain the elements required to replicate promoter behavior in a heterologous construct but it remains possible that regulatory elements beyond this sequence are required for proper p2 function. Furthermore, we linked these promoters to reporter genes and tested them in strain YB-392, whereas Ochoa-Estopier and Guillouet [@bib28] measured native gene transcription in the W29 *Y. lipolytica* wild-type strain. These native gene transcripts could differ from *FAD2* and *OLE1* in transcript stability. Finally, we cultivated our strains in nitrogen-limited, excess glucose batch fermentation as opposed to the chemostat and D-stat cultivation system used in Ochoa-Estopier and Guillouet [@bib28]. It is possible that p2 responds differently to these different process conditions for lipid production than the other promoters in our study.

Our work did not probe the mechanism through which promoter activity is regulated. Our initial promoter selection was based on transcriptional response to the C:N ratio in the media and our desaturase expression experiments were carried out in a high C:N batch fermentation where the cells transition from growth to lipid accumulation when the nitrogen is exhausted. In addition, the two most active promoters in our experiments, p1 and p5, are associated with genes predicted to encode amino acid permeases (Table [2](#tbl2){ref-type="table"}). Therefore, we speculate that low nitrogen levels or downstream signals may regulate promoter activity.

Promoters with reduced activity during the lipid accumulation phase are particularly interesting when applied to the expression of an essential gene. Strains carrying *OLE1* under the control of p1, p4 or p5 supplied enough Δ9 desaturase activity to maintain growth but restricted this activity to growth phase, leading to a defect in lipid accumulation upon nitrogen limitation. Low Δ9 desaturase activity uniformly led to a severe reduction in lipid body size and reduced Δ9 desaturase products, demonstrating the power of this method to specifically affect the lipid accumulation phase. Genes that are essential or favorable for growth can be supplied under the control of these promoters to specifically reduce their activities during lipid production for such purposes as altering lipid composition, improving yield through alternate pathways or eliminating side-products. This regulation can be achieved without changing the fermentation process because promoter activity is tied to the established process of lipid production in *Y. lipolytica*.

Although p1, p3--p5 have in common the ability to restrict activity to the growth phase, these promoters exhibit a range of phenotypes illustrated by the range of fatty acid compositions observed during growth (Figs [3a](#fig3){ref-type="fig"} and [6a](#fig6){ref-type="fig"}). These differences are likely due to differences in promoter strength, copy number, the timing of transcriptional repression and may also be affected by translational efficiency. The rates at which each promoter transitions from maximum to minimum expression as well as the level of expression at these timepoints are possibly key determinants of enzyme levels during these fermentations. The optimum level and timing of activity for a targeted enzyme will depend on the pathway, properties (enzyme kinetics, protein half-life) and experimental objectives. The availability of a set of promoters capable of turning off a targeted activity with a range of expression patterns and without the necessity of additional fermentation control mechanisms will provide a valuable tool for fine-tuning activity levels.
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======================
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Click here for additional data file.
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